Phase II Study of Irinotecan (CPT-11) in Children and Adolescents With High Risk Ewing's Sarcoma
Phase of Trial: Phase II
Latest Information Update: 25 Jun 2013
At a glance
- Drugs Irinotecan (Primary)
- Indications Ewing's sarcoma
- Focus Therapeutic Use
- 10 Oct 2009 Additional lead trial investigator (Porter L) identified as reported by United Kingdom Clinical Research Network.
- 10 Oct 2009 New source identified and integrated (United Kingdom Clinical Research Network).
- 07 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.